Pneumococcal Vaccines — CPB 0037 | AETNA Coverage Update

Aetna modified CPB 0037 for pneumococcal vaccines, effective March 3, 2026. Here's what billing teams need to update before claims go out the door.

Aetna, a CVS Health company, revised its pneumococcal vaccine coverage policy under CPB 0037 Aetna system, adding PCV21 (Capvaxive) as a covered vaccine and expanding adult dosing guidance across age groups. The primary codes affected are CPT 90671 (PCV15), 90677 (PCV20), 90684 (PCV21), and 90732 (PPSV23), along with administration codes 90460, 90471, and HCPCS G0009. If your practice vaccinates adults or children under any Aetna plan, this policy update changes which vaccine sequences Aetna considers medically necessary — and which it doesn't.

---

Quick-Reference Table

Field	Detail Copy
Payer	Aetna, a CVS Health company
Policy	Pneumococcal Vaccines — CPB 0037
Policy Code	CPB 0037
Change Type	Modified
Effective Date	March 3, 2026
Impact Level	Medium-High
Specialties Affected	Primary care, internal medicine, pediatrics, infectious disease, immunology
Key Action	Update charge capture and vaccine sequence documentation to reflect PCV21 coverage and new adult dosing paths before submitting claims under this policy

---

Aetna Pneumococcal Vaccine Coverage Criteria and Medical Necessity Requirements 2026

Aetna's pneumococcal vaccine coverage policy recognizes four vaccines: PCV15 (Vaxneuvance, CPT 90671), PCV20 (Prevnar 20, CPT 90677), PCV21 (Capvaxive, CPT 90684), and PPSV23 (Pneumovax 23, CPT 90732). Coverage aligns with CDC ACIP recommendations. The real issue here is sequencing — which vaccine you gave before, and which one you give next, determines whether Aetna pays.

Infants and Children (Under 6 Years)

PCV15 or PCV20 is medically necessary for all children aged two through 59 months. Children who started their series with PCV13 (Prevnar 13) can finish with PCV15 or PCV20. That's straightforward.

Catch-up vaccination gets more specific. Healthy children aged 24 through 59 months with incomplete vaccination status qualify for PCV15 or PCV20. Children aged 24 through 71 months with underlying health conditions that raise their pneumococcal disease risk qualify for the same catch-up path.

Children Ages 2–18 With Risk Conditions

This is where prior authorization risk rises — the rules branch based on what the child received previously.

If a child aged two through 18 with a risk condition received all recommended PCV doses before age six and got at least one dose of PCV20, additional pneumococcal vaccines are not medically necessary. Bill additional doses and expect a claim denial.

If that same child received PCV13 or PCV15 without a PCV20 dose, one dose of PCV20 (CPT 90677) or PPSV23 (CPT 90732) is medically necessary. Document the prior vaccine history in the chart — Aetna will want to see it.

For children aged six through 18 with risk conditions who never received PCV13, PCV15, or PCV20, a single dose of PCV15 or PCV20 is covered. If PCV15 is used, Aetna follows ACIP's recommendation for a PPSV23 follow-up at least eight weeks later.

Adults Ages 19–49

Coverage for this group requires an underlying health condition that increases pneumococcal disease risk. Without that documented condition, medical necessity doesn't apply under this policy.

For adults 19–49 who haven't previously received a pneumococcal conjugate vaccine — or whose history is unknown — PCV15, PCV20, or PCV21 is covered. The sequencing rules matter here:

Adults 50 and Older

All adults 50 and older who haven't received a pneumococcal conjugate vaccine — or whose history is unknown — qualify for PCV15, PCV20, or PCV21. No risk condition required. This is the most straightforward group to document.

The same sequencing logic applies: PCV15 requires a PPSV23 follow-up at least one year later (eight weeks minimum for high-risk patients). PCV20 or PCV21 completes the series alone.

Adults who previously received PPSV23 but no conjugate vaccine can receive PCV15, PCV20, or PCV21 at least one year after their last PPSV23. Adults who previously received PCV13 can receive PCV20 or PCV21 at least one year later.

The prior authorization requirement isn't explicitly called out as mandatory in this policy, but incomplete or inconsistent prior vaccine documentation is a fast path to denials — especially for adults in the 19–49 group where the risk-condition requirement applies. Talk to your compliance officer if you're unsure how your Aetna contracts handle PA for vaccine administration.

---

Aetna Pneumococcal Vaccine Exclusions and Non-Covered Indications

One code is explicitly not covered for indications listed in this CPB: CPT 87652 (Infectious agent detection by nucleic acid, Streptococcus, group A, quantification). This is a diagnostic test, not a vaccine, and Aetna draws a hard line here.

Don't bill 87652 expecting reimbursement under a pneumococcal vaccine encounter. It won't pay. If you're running diagnostic testing alongside vaccination, those claims need separate clinical justification and should not be bundled under CPB 0037 Aetna coverage.

---

Coverage Indications at a Glance

---

Aetna Pneumococcal Vaccine Billing Guidelines and Action Items 2026

Pneumococcal vaccine billing is detail-sensitive. Small documentation gaps — missing prior vaccine history, wrong sequencing — produce denials that are hard to overturn. Here's what to do before the March 3, 2026 effective date passes and claims start moving through.

Copy Action Items

If you're billing across a high volume of Aetna members or your panel skews toward adults 19–49 with chronic conditions, have your compliance officer review the risk-condition documentation standards before March 3, 2026. The financial exposure from systematic underdocumentation in that cohort adds up fast.

---

CPT, HCPCS, and ICD-10 Codes for Pneumococcal Vaccines Under CPB 0037

Covered CPT Codes (When Selection Criteria Are Met)

Not Covered CPT Codes

Code	Type	Description	Reason Copy
87652	CPT	Infectious agent detection by nucleic acid (DNA or RNA); Streptococcus, group A, quantification	Not covered for indications listed in CPB 0037

Administration and Counseling CPT Codes (Related to CPB 0037)

Covered HCPCS Codes (When Selection Criteria Are Met)

Code	Type	Description Copy
G0009	HCPCS	Administration of pneumococcal vaccine

Other HCPCS Codes (Related to CPB 0037)

Key ICD-10-CM Diagnosis Codes

Code	Description Copy
A30.0–A49.9	Other bacterial diseases
Z23	Encounter for immunization (pneumococcus)

---